Altris AI, a provider of artificial intelligence for OCT scan analysis, unveiled additional quantification features for Fluids and Geographic Atrophy (GA) tracking on its web platform.
Altris AI currently detects over 70 retina pathologies and biomarkers. However, the company said it decided to enhance its capabilities by adding additional Fluids and GA quantification and tracking functionalities, recognising that eyecare specialists frequently work with these conditions.
These advancements are designed to empower eyecare professionals (ECPs) with tools for diagnosing and managing retinal diseases.
By integrating AI-driven quantitative tracking and progression monitoring, Altris AI says it ‘enables specialists to deliver more personalised and effective treatments, ultimately enhancing patient outcomes.’
